H|T: The Healthtech Times – Toronto biotech secures $2.2M to treat immune diseases
Plus: Healthcare startup Tempus preps for IPO.
Alex Riehl is a staff writer and newsletter curator at BetaKit with a Bachelor of Journalism from Carleton University. He's interested in tech, gaming, and sports. You can find out more about him at alexriehl.com or @RiehlAlex99 on Twitter.
Plus: Healthcare startup Tempus preps for IPO.
AI-powered product can answer legal, finance, or tax queries in 170 languages.
The funding will help increase the startup’s global footprint, establish partnerships, and improve its platform.
Plus: Plenty of Fish founder Markus Frind catches new CEO gig.
AstraZeneca says the deal marks “a major step forward” in its goal to transform cancer treatment.
The Sustainable Manufacturing Challenge is seeking projects that will support Canada’s net-zero goals.
Plus: Canada may be losing ground in AI research race.
Busbud says it now has over 600 partnerships with bus operators in LATAM.
Plus: MDF Commerce agrees to go private, but some shareholders raise a fuss.
The funding is aimed at supporting research into sustainability and responsible AI development.
Nuvei has formed a special committee to evaluate “expressions of interest” the company has seen.
Plus: Open banking framework is coming, but adoption? Not so soon.
Plus: Vancouver looks to join the global big leagues of modern medicine.
The platform is backed by GitHub CEO Thomas Dohmke.
The acquisition values the workflow platform at approximately $150 million.